
Sign up to save your podcasts
Or


Jared, Vanessa and Adam are joined by Steve Maike, Chief Pharmacy Officer for Remedy Analytics (part of the Brown & Brown team), and Alan Pannier, Vice President of Strategy with SmithRx. The team leads a discussion around strategies and best practices for employers to help confront the rising costs of pharmaceuticals for employers. Pharmacy cost increases are projected to be 9.8% with specialty drugs leading that trend, up almost 13.5% in 2023. The team covers strategies from highlighting biosimilars, gene therapy, navigational resources and recent legislation directly impacting employers on their pharmacy plans.
Connect with the hosts:
Jared Bowcutt
Vanessa Longnecker
Adam Compton
By Brown & Brown5
2727 ratings
Jared, Vanessa and Adam are joined by Steve Maike, Chief Pharmacy Officer for Remedy Analytics (part of the Brown & Brown team), and Alan Pannier, Vice President of Strategy with SmithRx. The team leads a discussion around strategies and best practices for employers to help confront the rising costs of pharmaceuticals for employers. Pharmacy cost increases are projected to be 9.8% with specialty drugs leading that trend, up almost 13.5% in 2023. The team covers strategies from highlighting biosimilars, gene therapy, navigational resources and recent legislation directly impacting employers on their pharmacy plans.
Connect with the hosts:
Jared Bowcutt
Vanessa Longnecker
Adam Compton

32,060 Listeners

229,220 Listeners

30,704 Listeners

8,772 Listeners

23 Listeners

112,611 Listeners

21,152 Listeners

207 Listeners

148 Listeners

26 Listeners

57,726 Listeners

40,325 Listeners

61,469 Listeners

2,167 Listeners

485 Listeners